- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
Dermatology Times, Digital Edition, June 2011
Disaster 101 : Is your practice prepared to meet the challenge? Restoring Skin : ReCell uses patient’s own cells to trigger regeneration Special Report : Men & skin
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Road to RAD: Taking Itch Into Consideration
SDNP President Amanda Caldwell, MSN, APRN-C, on Empowering NPs Through Enhanced Support and Education
Derm Dispatch: Melanoma Doesn’t Wait—Neither Should You
Road to RAD: Lebrikizumab for AD
From Patient to President: Amanda Caldwell, MSN, APRN-C, And Her Journey with SDNP
Road to RAD: Nemolizumab for AD
Revolutionizing Acne Treatments and Skin Care with Cold Plasma Technology
Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD
Julia Zimmermann PD, PhD, Demonstrates PHLAS, A New Cold Plasma Skin Care Device
Weighing In on Biologics and JAK Inhibitors for Atopic Dermatitis
Related Content
